中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Aptamer-Mediated Up-conversion Core/MOF Shell Nanocomposites for Targeted Drug Delivery and Cell Imaging

文献类型:期刊论文

作者Deng,Kerong; Hou,Zhiyao; Li,Xuejiao; Li,Chunxia; Zhang,Yuanxin; Deng,Xiaoran; Cheng,Ziyong; Lin,Jun
刊名scientific reports
出版日期2015
卷号5页码:7851
关键词METAL-ORGANIC FRAMEWORKS PHOTOTHERMAL THERAPY NANOPARTICLES CANCER NANOMATERIALS ENCAPSULATION CHALLENGES SILICA PROBES
通讯作者lin,j
英文摘要multifunctional nanocarriers for targeted bioimaging and drug delivery have attracted much attention in early diagnosis and therapy of cancer. in this work, we develop a novel aptamer-guided nanocarrier based on the mesoporous metal-organic framework (mof) shell and up-conversion luminescent nayf4:yb3+/er3+ nanoparticles (ucnps) core for the first time to achieve these goals. these ucnps, chosen as optical labels in biological assays and medical imaging, could emit strong green emission under 980 nm laser. the mof structure based on iron (iii) carboxylate materials [mil-100 (fe)] possesses high porosity and non-toxicity, which is of great value as nanocarriers for drug storage/delivery. as a unique nanoplatform, the hybrid inorganic-organic drug delivery vehicles show great promising for simultaneous targeted labeling and therapy of cancer cells.
收录类别SCI
语种英语
公开日期2016-05-09
源URL[http://ir.ciac.jl.cn/handle/322003/64846]  
专题长春应用化学研究所_长春应用化学研究所知识产出_期刊论文
推荐引用方式
GB/T 7714
Deng,Kerong,Hou,Zhiyao,Li,Xuejiao,et al. Aptamer-Mediated Up-conversion Core/MOF Shell Nanocomposites for Targeted Drug Delivery and Cell Imaging[J]. scientific reports,2015,5:7851.
APA Deng,Kerong.,Hou,Zhiyao.,Li,Xuejiao.,Li,Chunxia.,Zhang,Yuanxin.,...&Lin,Jun.(2015).Aptamer-Mediated Up-conversion Core/MOF Shell Nanocomposites for Targeted Drug Delivery and Cell Imaging.scientific reports,5,7851.
MLA Deng,Kerong,et al."Aptamer-Mediated Up-conversion Core/MOF Shell Nanocomposites for Targeted Drug Delivery and Cell Imaging".scientific reports 5(2015):7851.

入库方式: OAI收割

来源:长春应用化学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。